Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · operational-macro

Sanara MedTech outlines cash-stock merger with MiMedx

11 August 2026 · By · Wire by Fusion42

Published

11 August 2026

Topic

operational-macro

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at stocktitan.net →

◆ Verified

Fusion42 · 23 August 2026 · Fusion42 review

Sanara MedTech Inc. has entered into a definitive merger agreement with MiMedx Group, Inc., where MiMedx will acquire Sanara MedTech through a cash-stock merger. The merger has been unanimously approved by both boards and will result in Sanara MedTech becoming a wholly-owned subsidiary of MiMedx.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

Merger activity in US medtech is accelerating, making it a ripe moment to explore service or product gaps newly exposed by Sanara MedTech's integration into MiMedx. If you supply to mid-sized medtech firms, reconsider your sales strategy now.

◆ Coverage

1 source · 11 Aug 2026

◆ Related on Wire

◆ Topics

Medtechmergermedtechacquisitioncorporate-governancestock-deal